Home › Funds › UBS Group AG › STRO
UBS Group AG position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)208.51K sh
Reported value held$6.92M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.22K | $23.00K | New |
| Q1 2022 | 110.33K | $907.00K | New |
| Q2 2022 | 3.72K | $19.00K | Reduce |
| Q3 2022 | 1.07K | $6.00K | Reduce |
| Q4 2022 | 72.66K | $587.12K | Add |
| Q1 2023 | 82.70K | $382.07K | Add |
| Q2 2023 | 30.06K | $139.80K | Reduce |
| Q3 2023 | 35.97K | $124.83K | Add |
| Q4 2023 | 59.59K | $255.65K | Add |
| Q1 2024 | 64.64K | $365.21K | Add |
| Q2 2024 | 31.35K | $91.86K | Reduce |
| Q3 2024 | 165.86K | $573.87K | Add |
| Q4 2024 | 183.66K | $337.94K | Add |
| Q1 2025 | 75.57K | $49.20K | Reduce |
| Q2 2025 | 1.62M | $1.16M | Add |
| Q3 2025 | 1.85M | $1.60M | Add |
| Q4 2025 | 7.87K | $91.06K | Reduce |
| Q1 2026 | 392.87K | $9.79M | Add |
| Q2 2026 | 208.51K | $6.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026